Status:
COMPLETED
The Incidence and the Risk Factors of Nephrocalcinosis in Very Preterm Infants
Lead Sponsor:
Vilnius University
Conditions:
Nephrocalcinosis
Preterm Infant
Eligibility:
All Genders
23-31 years
Brief Summary
The study aims to assess the incidence and the risk factors of nephrocalcinosis in very preterm infants using patient data collected during hospitalisation at the Neonatology Centre.
Detailed Description
Nephrocalcinosis in preterm infants develops as a result of imbalance between the factors promoting or inhibiting formation of kidney stones. It is caused by intensive treatment as well as functional ...
Eligibility Criteria
Inclusion
- preterm infants of the gestational age of \<32 weeks;
- parental consent acquired.
Exclusion
- death before 28 days of age;
- congenital defects;
- no kidney ultrasound results;
- no parental consent.
Key Trial Info
Start Date :
October 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
171 Patients enrolled
Trial Details
Trial ID
NCT04382976
Start Date
October 1 2018
End Date
October 1 2021
Last Update
December 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vilnius University, Neonatology Centre
Vilnius, Lithuania, 08464